The Board of Directors of Themis Medicare Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23 and H1FY23.
The board of directors of Themis Medicare Ltd has approved an agreement to sell the Active Pharmaceutical ingredients business of the Company to Themis Lifestyle Private Limited.